title: Memantine-associated corneal endothelial dysfunction.
authors.affiliation: Price Vision Group, Indianapolis, Indiana.
authors.forename: Matthew T
authors.initials: MT
authors.lastname: Feng
authors.affiliation: Price Vision Group, Indianapolis, Indiana.
authors.forename: Francis W
authors.initials: FW
authors.lastname: Price
authors.affiliation: Price Vision Group, Indianapolis, Indiana.
authors.forename: Yuri
authors.initials: Y
authors.lastname: McKee
authors.affiliation: Cornea Research Foundation of America, Indianapolis, Indiana.
authors.forename: Marianne O
authors.initials: MO
authors.lastname: Price
mesh_terms: D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy; D003316:Corneal Diseases / Q000139:chemically induced* / Q000503:physiopathology; D057111:Descemet Stripping Endothelial Keratoplasty; D004728:Endothelium, Corneal / Q000187:drug effects* / Q000503:physiopathology; D018691:Excitatory Amino Acid Antagonists / Q000009:adverse effects*; D005260:Female; D005642:Fuchs' Endothelial Dystrophy / Q000601:surgery; D006084:Graft Rejection / Q000139:chemically induced* / Q000503:physiopathology; D006801:Humans; D008559:Memantine / Q000009:adverse effects*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D012086:Reoperation; D041623:Tomography, Optical Coherence
chemical_list: D018691:Excitatory Amino Acid Antagonists; D016194:Receptors, N-Methyl-D-Aspartate; D008559:Memantine